Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Breast Neoplasms 74Colorectal Neoplasms 41Central Nervous System Neoplasms 37Colonic Neoplasms 36Rectal Neoplasms 34Glioblastoma 23Carcinoma, Non-Small-Cell Lung 21Gliosarcoma 20Stomach Neoplasms 18Lung Neoplasms 18Pancreatic Neoplasms 16Head and Neck Neoplasms 16Sarcoma 14Ovarian Neoplasms 14Squamous Cell Carcinoma of Head and Neck 13Prostatic Neoplasms 12Neoplasm Metastasis 11Melanoma 11Esophageal Neoplasms 11Carcinoma, Ovarian Epithelial 11Carcinoma, Intraductal, Noninfiltrating 11Astrocytoma 11Fallopian Tube Neoplasms 10Brain Neoplasms 10Uterine Cervical Neoplasms 9Kidney Neoplasms 9Breast Carcinoma In Situ 9Liver Neoplasms 8Breast Neoplasms, Male 8Adenocarcinoma Of Esophagus 8

Interventions

Cisplatin 41Gemcitabine 25Radiotherapy, Intensity-Modulated 15Fluorouracil 15Radiotherapy 12Docetaxel 10pembrolizumab 8Paclitaxel 8Carboplatin 8Capecitabine 7Oxaliplatin 5toripalimab 4spartalizumab 4Surveys and Questionnaires 4Bevacizumab 4camrelizumab 3Nivolumab 3Induction Chemotherapy 3Immunohistochemistry 3Endostatins 3Counseling 3Cetuximab 3Acupuncture Therapy 3tislelizumab 2sintilimab 2nimotuzumab 2endostar protein 2apatinib 2Taxes 2Psychiatric Rehabilitation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Nasopharyngeal Neoplasms × Chemotherapy, Adjuvant × Clear all
NCT00370890 2022-02-17

A Trial of Adjuvant Chemotherapy in Nasopharyngeal Carcinoma Patients With Residual Epstein-Barr Virus (EBV) DNA Following Radiotherapy

Chinese University of Hong Kong

Phase 3 Completed
104 enrolled
Head & Neck

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡